FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Method and kit for investigating the presence of cytomegalovirus (CMV), herpes simplex virus I (HSV I), herpes simplex virus II (HSV II), Epstein-Barr virus (EBV), HHV6, HHV7, HHV8, parvovirus 19, hepatitis B virus (HBV), hepatitis C virus (HCV), coxsackie virus, human immunodeficiency viruses (HIV-1, HIV-2), adeno-associated virus (AAV), rubella virus, HPV, chlamydia, toxoplasma and norovirus inside the sperm cells.
EFFECT: proposed group of inventions provides effective detection of microorganisms within the spermatozoa by applying a procedure for facilitating the dense structure of the DNA of seminal fluid cells.
13 cl, 3 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CELL POPULATION DISCRIMINATION AND APPLICATION THEREOF | 2006 |
|
RU2397494C2 |
| METHOD AND MEANS FOR MONITORING OF TISSUE HOMEOSTASIS IN ORGANISM | 2012 |
|
RU2635767C2 |
| METHODS FOR DETECTION OF ANTI-CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES | 2013 |
|
RU2660712C2 |
| METHOD FOR QUANTITATIVE DETERMINATION OF VIRAL INFECTION OF SPERM CELLS | 2020 |
|
RU2738798C1 |
| METHOD OF TREATMENT OF PATIENTS WITH UROGENITAL CHLAMYDIUM, UREAPLASMA AND MYCOPLASMA INFECTION | 1995 |
|
RU2137483C1 |
| ASSAY FOR MEASURING CELL-MEDIATED IMMUNORESPONSIVENESS | 2010 |
|
RU2605381C2 |
| VACCINE COMPOSITIONS AND METHODS OF USE THEREOF | 2010 |
|
RU2600798C2 |
| NANOANTIBODIES BINDING CHLAMYDIA TRACHOMATIS ANTIGEN, METHOD OF INHIBITING INFECTION CAUSED BY CHLAMYDIA TRACHOMATIS | 2012 |
|
RU2487724C1 |
| METHOD OF DETECTION OF CELL-FREE DNA IN WHOLE PERIPHERAL BLOOD USING FLOW CYTOMETRY | 2022 |
|
RU2815709C1 |
| DIAGNOSTIC TECHNIQUE FOR PERSISTENT LATENT BACTERIAL INFECTION WITH ASSOCIATING VESSEL WALL INVOLVEMENT | 2009 |
|
RU2414714C1 |
